Lisa Kearns, MS, MA

Lisa Kearns, MS, MA, is a senior researcher in the Division of Medical Ethics at NYU Grossman
School of Medicine. She is a member of the Division’s working groups on Compassionate Use
and Preapproval Access (CUPA) and Pediatric Gene Therapy and Medical Ethics (PGTME).
For the past six years she has studied the ethical issues surrounding preapproval/expanded
access to investigational drugs with an emphasis on state and federal “right to try”
legislation. More recently she has been studying the ethics of “customized” N-of-1 gene
therapies and of preapproval access to gene therapies. She is the deputy chair of the
Compassionate Use Advisory Committees (CompAC), which advise Janssen Pharmaceuticals
on the ethical allocation of its investigational drugs, and is a participant in the NYU-University of Ghana Research Integrity Training Program, a Fogarty-funded program that is working to build research integrity capacity in Ghana.